Mad in America

DECEMBER 31, 2024

The findings reinforce the view that addressing the high prevalence rates of depression via symptom recognition and treatment with antidepressants is unlikely to be effective. The absolute long-term efficacy of antidepressants in real-world settings is disappointingly modest.

Genetics and mental health 141

Genetics and mental health Poverty and mental health Resilience and coping Global mental health 141

Lightwork

FEBRUARY 20, 2025

The right SAD lamp, positioned correctly at your desk or breakfast table, can significantly impact your daily mood and energy levels.

Sleep and mental health 52

Sleep and mental health Aging and mental health Cognitive Behavioral Therapy Mindfulness practices 52

Mad in America

JANUARY 1, 2024

S ome of the following studies appeared in my book Antidepressants: Science, Magic or Marketing , 1 and in the next section, I will report on some of the more recent depression treatment outcome studies. even getting on a waiting list for treatment), the severity of their depression lessons in most cases.

Healthcare 83

Healthcare Self-awareness Genetics and mental health Cognitive Behavioral Therapy 83

Mad in America

APRIL 27, 2024

This was a story of a great medical advance, and the announced results from the STAR*D trial, heralded by the NIMH as the “largest and longest study ever done to evaluate depression treatment,” fit into that story of medical progress, for it told of 70% of depressed patients becoming “symptom free” after repeated treatments with antidepressants.

Self-awareness 145

Self-awareness Depression treatment 145

My Psychiatry

JANUARY 14, 2025

Postpartum Depression Treatment There are different ways of treating PPD depending on the symptoms and their severity. Available treatment options include psychotherapy, antidepressant or anti-anxiety medications, and participation in support groups for emotional support.

Sleep and mental health 52

Sleep and mental health Aging and mental health Depression treatment 52

Bullet Psych

OCTOBER 7, 2022

Pharmacotherapy : Fluoxetine is the only FDA approved medication for the treatment of bulimia nervosa (in adults) and should be considered as the first-line medication option. The effective dose is typically higher than average depression treatment (60-80 mg/day). Other SSRIs (e.g.

Eating disorders 52

Eating disorders Dialectical Behavior Therapy Cognitive Behavioral Therapy Personality disorders 52

Chipur

MARCH 6, 2025

Its been six months now. You still dont like the episodes, but you feel safe enough to be curious. I have to admit its interesting. I mean, why does my brain do this? Derealization and depersonalization: Perceived madness - exploring. Lets do some. The post Derealization and depersonalization: Perceived madness | 3 appeared first on Chipur.

Bipolar disorder 91

Bipolar disorder Depression treatment 91

Bullet Psych

JANUARY 22, 2023

Fluoxetine is FDA approved for the treatment of bulimia nervosa (in adults) which has been shown to reduce frequency of binge eating, however it is technically an off-label use for BED. The effective dose is typically higher than average depression treatment (60-80 mg/day). Other SSRIs (e.g.

Eating disorders 52

Eating disorders Dialectical Behavior Therapy Cognitive Behavioral Therapy Personality disorders 52

Bullet Psych

OCTOBER 2, 2023

Question 2 : From day # 147 Answer : b Bulimia nervosa Explanation: 3 Pharmacotherapy for bulimia nervosa : Fluoxetine is the only FDA approved medication for the treatment of bulimia nervosa (in adults) and should be considered as the first-line medication option. Other SSRIs (e.g.

Eating disorders 52

Eating disorders Hospitality Sleep and mental health Depression treatment 52

Mad in America

JANUARY 3, 2024

However, there was recognition within the NIMH that that the industry-funded trials didn’t necessarily provide evidence of the efficacy of antidepressants in real-world patients, which prompted it to launch the STAR*D study, touting it as the “largest and longest study ever done to evaluate depression treatment.”

Neurotransmitters and mental health 144

Neurotransmitters and mental health Hospitality Education Self-awareness 144

Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct.

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Chipur

MARCH 1, 2025

Its like you suddenly lost your grip on immediate reality. Or maybe you looked in a mirror and a full sense of you didnt hit home. Derealization and depersonalization: perceived madness - the more we learn, the saner we feel. The post Derealization and depersonalization: Perceived madness | 2 appeared first on Chipur.

Bipolar disorder 61

Bipolar disorder Depression treatment 61

Mad in America

NOVEMBER 20, 2023

Antipsychotics for psychotic depression? Adding an antipsychotic drug to antidepressant treatment increased the risk of death and rehospitalization for people with the psychotic depression diagnosis. Our findings do not indicate any advantage of adding antipsychotics as adjunctive to antidepressants as maintenance treatment.

Hospitality 145

Hospitality Depression treatment 145

Mad in America

JUNE 20, 2024

The eighties and nineties were a depression-treatment renaissance. It is undeniable that it has been helpful for the pharmaceutical industry, which continues to grow yearly, and as of 2022, the antidepressant market has reached $17.02 billion worldwide.

Pharmaceuticals 139

Pharmaceuticals Manufacturing Construction Depression treatment 139

Zencare

JANUARY 22, 2025

Types of antidepressants : Selective serotonin reuptake inhibitors (SSRIs) The most frequently prescribed medications for depression. Treatment includes symptom reduction and remission. Tricyclic antidepressants These are not used very often for depression due to side effects, toxicity, and suicide potential.

Neurotransmitters and mental health 52

Neurotransmitters and mental health Bipolar disorder Sleep and mental health Genetics and mental health 52

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145

Mad in America

SEPTEMBER 18, 2024

The first NIMH treatment outcome study , which was published in 1989, found the drug treatment (imipramine) to be no more effective than placebo when measures were taken after three months of treatment.

Aging and mental health 145

Aging and mental health Cognitive Behavioral Therapy Manufacturing Anxiety disorders 145